Jeffrey Lamping, MD | |
1400 Mercy Dr Ste 100a, Muskegon, MI 49444-1819 | |
(231) 830-2739 | |
Not Available |
Full Name | Jeffrey Lamping |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery |
Location | 1400 Mercy Dr Ste 100a, Muskegon, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801247739 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207XS0117X | Orthopaedic Surgery - Orthopaedic Surgery Of The Spine | 4301117300 (Michigan) | Secondary |
207X00000X | Orthopaedic Surgery | 4301109786 (Michigan) | Primary |
Entity Name | Orthopaedic Associates Of Muskegon Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972566594 PECOS PAC ID: 7214908045 Enrollment ID: O20040804000844 |
News Archive
Halozyme Therapeutics, Inc. today announced the commencement of a Phase 1 clinical study that will assess the effects of three approved prandial (mealtime) insulin analogs administered with its proprietary rHuPH20 (PH20) hyaluronidase enzyme compared to each of the analogs alone. This randomized, three-way cross-over design, euglycemic clamp study will compare the postprandial pharmacokinetics (PK) and glucodynamics (GD) of the insulin analogs.
Stroke survivors who have an irregular heartbeat called atrial fibrillation may be at higher risk of developing dementia than stroke survivors who do not have the heart condition, according to research published in the March 8, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Babies who suffer oxygen deficiencies during birth are at risk of brain damage that can lead to developmental delays, cerebral palsy and even death.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from the first double-blind, placebo-controlled clinical study to evaluate BYETTA (exenatide) injection added to Lantus (insulin glargine), which showed patients with type 2 diabetes achieved glucose targets without weight gain or increasing their risk of hypoglycemia. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association in Orlando, Fla.
› Verified 3 days ago
Entity Name | Beaumont Medical Group- Specialty Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578072906 PECOS PAC ID: 7214299866 Enrollment ID: O20180320002549 |
News Archive
Halozyme Therapeutics, Inc. today announced the commencement of a Phase 1 clinical study that will assess the effects of three approved prandial (mealtime) insulin analogs administered with its proprietary rHuPH20 (PH20) hyaluronidase enzyme compared to each of the analogs alone. This randomized, three-way cross-over design, euglycemic clamp study will compare the postprandial pharmacokinetics (PK) and glucodynamics (GD) of the insulin analogs.
Stroke survivors who have an irregular heartbeat called atrial fibrillation may be at higher risk of developing dementia than stroke survivors who do not have the heart condition, according to research published in the March 8, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Babies who suffer oxygen deficiencies during birth are at risk of brain damage that can lead to developmental delays, cerebral palsy and even death.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from the first double-blind, placebo-controlled clinical study to evaluate BYETTA (exenatide) injection added to Lantus (insulin glargine), which showed patients with type 2 diabetes achieved glucose targets without weight gain or increasing their risk of hypoglycemia. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association in Orlando, Fla.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Jeffrey Lamping, MD 676 N Saint Clair St Ste 1350, Chicago, IL 60611-4795 Ph: (312) 926-4444 | Jeffrey Lamping, MD 1400 Mercy Dr Ste 100a, Muskegon, MI 49444-1819 Ph: (231) 830-2739 |
News Archive
Halozyme Therapeutics, Inc. today announced the commencement of a Phase 1 clinical study that will assess the effects of three approved prandial (mealtime) insulin analogs administered with its proprietary rHuPH20 (PH20) hyaluronidase enzyme compared to each of the analogs alone. This randomized, three-way cross-over design, euglycemic clamp study will compare the postprandial pharmacokinetics (PK) and glucodynamics (GD) of the insulin analogs.
Stroke survivors who have an irregular heartbeat called atrial fibrillation may be at higher risk of developing dementia than stroke survivors who do not have the heart condition, according to research published in the March 8, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Babies who suffer oxygen deficiencies during birth are at risk of brain damage that can lead to developmental delays, cerebral palsy and even death.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from the first double-blind, placebo-controlled clinical study to evaluate BYETTA (exenatide) injection added to Lantus (insulin glargine), which showed patients with type 2 diabetes achieved glucose targets without weight gain or increasing their risk of hypoglycemia. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association in Orlando, Fla.
› Verified 3 days ago
Dr. Daniel J Fett, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1314 E Apple Ave, Muskegon, MI 49442 Phone: 231-777-2568 Fax: 231-773-4310 | |
Jefferson Christopher Eyke, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Mercy Dr., Muskegon, MI 49444 Phone: 231-733-1326 Fax: 231-733-5212 | |
Jeffrey D Recknagel, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Mercy Dr., Muskegon, MI 49444 Phone: 231-733-1326 Fax: 231-733-5212 | |
Brandon King, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Mercy Dr, Muskegon, MI 49444 Phone: 231-733-1326 Fax: 231-733-5212 | |
Dr. Aaron Daniel Potts, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Mercy Dr, Ste 100, Muskegon, MI 49444 Phone: 231-733-1326 Fax: 231-733-0449 | |
Martin M Pallante, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Mercy Dr., Suite 100, Muskegon, MI 49444 Phone: 231-733-1326 Fax: 231-733-5212 | |
Christine Bowman, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Mercy Dr Ste 100, Muskegon, MI 49444 Phone: 231-733-1326 |